---
{"dg-publish":true,"permalink":"/USMLE/Pharmacology/Acetaminophen poisoning/"}
---

# Epidemiology
---
<span style="background:rgba(240, 200, 0, 0.2)">Leading cause of acute liver failure</span>

# Etiology
---


# Pathophysiology
---
- <span style="background:rgba(240, 200, 0, 0.2)">Exhaustion of hepatic metabolic pathways causes accumulation of a toxic metabolite of [[USMLE/Pharmacology/Non-opioid analgesics\|acetaminophen]], N-acetyl-p-benzoquinoneimine (NAPQI).</span> 
	- <span style="background:rgba(240, 200, 0, 0.2)">Glutathione initially inactivates NAPQI, but its reserves are eventually depleted, leading to NAPQI accumulation.</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">NAPQI → irreversible oxidative hepatocyte injury → liver cell necrosis</span>![Pasted image 20250608170851.png](/img/user/appendix/Pasted%20image%2020250608170851.png)
- APAP-induced hepatotoxicity
	- Defined as peak AST or ALT > 1000 IU/L
	- Most commonly caused by APAP overdose
	- Occurs rarely at therapeutic doses in patients with: 
		- <span style="background:rgba(240, 200, 0, 0.2)">Alcohol consumption</span>
		- Prolonged fasting
		- Chronic liver disease

# Clinical features
---
- Nausea, vomiting
- Pallor
- RUQ pain
- Signs of acute liver failure

# Diagnostics
---

# Differential diagnostics
---

| Feature             | [[USMLE/Pharmacology/Salicylate poisoning\|Salicylate (ASA) Poisoning]] | [[USMLE/Pharmacology/Non-opioid analgesics\|Acetaminophen]] (APAP) Poisoning           | [[USMLE/Pharmacology/Reye syndrome\|Reye Syndrome]]                                         |
| :------------------ | :--------------------------------------------------- | :------------------------------------------------------------------ | :-------------------------------------------------------- |
| **Classic Hx**      | Overdose (intentional/accidental)                    | Intentional OD; chronic EtOH use                                    | Child after viral illness + ASA use                       |
| **Pathophysiology** | Uncouples ox-phos; <br>Resp center stim;<br>Direct **ototoxicity**  | Glutathione depletion -> toxic metabolite (NAPQI) -> liver necrosis | Mitochondrial dysfunction -> fatty liver & encephalopathy |
| **Presentation**    | **Tinnitus**, fever, hyperventilation, AMS           | Asymptomatic initially -> RUQ pain -> fulminant liver failure       | Profuse vomiting, [[USMLE/Psychiatry/Delirium\|delirium]]/coma, **NO jaundice**      |
| **Key Lab Finding** | **Mixed resp. alkalosis + metabolic acidosis**       | **Massive AST/ALT elevation** (>1000s)                              | **[[USMLE/Biochemistry/Hyperammonemia\|Hyperammonemia]]**, elevated LFTs, [[USMLE/Endocrine/Hypoglycemia\|hypoglycemia]]   |
| **Antidote / Tx**   | **IV Sodium Bicarbonate**, Hemodialysis              | **N-acetylcysteine (NAC)**                                          | Supportive care (manage ICP, [[USMLE/Endocrine/Hypoglycemia\|hypoglycemia]])            |
| **Buzzword**        | "Mixed acid-base disorder"                           | "Rumack-Matthew nomogram"                                           | "Child + virus + aspirin"                                 |

# Treatment
---
- Antidote: PO or IV <span style="background:rgba(240, 200, 0, 0.2)">N-acetylcysteine (NAC)</span> is used to treat and prevent APAP-induced hepatoxicity.
	- <span style="background:rgba(240, 200, 0, 0.2)">NAC regenerates glutathione</span>
